A detailed history of Black Rock Inc. transactions in Adicet Bio, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 1,017,451 shares of ACET stock, worth $986,927. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,017,451
Previous 3,373,232 69.84%
Holding current value
$986,927
Previous $7.93 Million 84.47%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$1.21 - $2.4 $2.85 Million - $5.65 Million
-2,355,781 Reduced 69.84%
1,017,451 $1.23 Million
Q1 2024

May 10, 2024

BUY
$1.76 - $3.45 $2.1 Million - $4.11 Million
1,190,557 Added 54.55%
3,373,232 $7.93 Million
Q4 2023

Feb 13, 2024

SELL
$1.11 - $1.89 $96,351 - $164,057
-86,803 Reduced 3.82%
2,182,675 $4.13 Million
Q3 2023

Nov 13, 2023

SELL
$1.37 - $3.4 $161,980 - $401,995
-118,234 Reduced 4.95%
2,269,478 $3.11 Million
Q2 2023

Aug 11, 2023

SELL
$2.13 - $7.13 $317,561 - $1.06 Million
-149,090 Reduced 5.88%
2,387,712 $5.8 Million
Q1 2023

May 12, 2023

SELL
$5.52 - $9.23 $48,664 - $81,371
-8,816 Reduced 0.35%
2,536,802 $14.6 Million
Q4 2022

Feb 13, 2023

BUY
$7.72 - $21.27 $3.36 Million - $9.27 Million
435,831 Added 20.66%
2,545,618 $22.8 Million
Q3 2022

Nov 14, 2022

BUY
$13.43 - $18.74 $3.5 Million - $4.89 Million
260,705 Added 14.1%
2,109,787 $30 Million
Q2 2022

Aug 12, 2022

BUY
$10.26 - $20.81 $2.37 Million - $4.81 Million
230,975 Added 14.27%
1,849,082 $27 Million
Q1 2022

May 12, 2022

BUY
$11.53 - $19.97 $1.91 Million - $3.31 Million
165,655 Added 11.41%
1,618,107 $32.3 Million
Q4 2021

Feb 10, 2022

BUY
$7.37 - $17.49 $1.5 Million - $3.57 Million
203,933 Added 16.33%
1,452,452 $25.4 Million
Q3 2021

Nov 09, 2021

BUY
$6.29 - $9.93 $83,065 - $131,135
13,206 Added 1.07%
1,248,519 $9.79 Million
Q2 2021

Aug 11, 2021

BUY
$9.19 - $15.93 $11.4 Million - $19.7 Million
1,235,313 New
1,235,313 $12.7 Million

Others Institutions Holding ACET

About Adicet Bio, Inc.


  • Ticker ACET
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,030,800
  • Market Cap $38.8M
  • Description
  • Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...
More about ACET
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.